Chamber and committees

NHS Boards are responsible for receiving and approving applications for the Scottish Dental Access Initiative (SDAI). Successful applications are then sent to the Scottish Government for processing.

As such, the Scottish Government does not hold information on how many SDAI applications have been received in the NHS Borders area, and this information is held by the Health Board.

There have been no applications sent to Scottish Government in the last 12 months.

Scottish Government does not hold this information centrally. Information in relation to the number of dental practices providing NHS dental services in the Dumfries and Galloway area is held by the Health Board.

All patients can self-refer to an Orthodontist, without having seen a General Dental Practitioner.

Orthodontists have access to all items of service within the NHS Statement of Dental Remuneration (SDR), should any preparatory work be required.

The Scottish Government has not provided funding to the Barbara Koerner Memorial Trust

Prescription numbers of sodium valproate are not collected by the Scottish Government.

As set out in this year’s Programme for Government and Scotland’s International Strategy, the Scottish Government intends to host an international food summit including a focus on promoting the sector and overall food security. Further detail will be announced in due course.

There are no reimbursement schemes available to patients who enter into a private arrangement with a dentist for treatment, and the Scottish Government has no locus for intervention.

NHS dental services will continue to be available to patients, and some patients may wish to travel outwith their local area to access NHS dental services. Patients who are not registered with a dentist are able to access emergency and urgent dental care through their local Board’s Public Dental Service clinic.

There are three Cannabis Based Products for Medicinal use (CBPMs) available on the NHS in Scotland to treat specific conditions. These are:

• Nabilone, a synthetic cannabinoid, as an add-on treatment for adults with chemotherapy-induced nausea and vomiting;
• Sativex ® , a combination of delta-9-tetrahydrocannabinol and cannabidiol for moderate to severe spasticity in adults with multiple sclerosis; and
• Epidyolex ® , a cannabidiol for treating seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.

The biggest barrier to the prescribing of other CBPMs on the NHS is that most products remain unlicensed with a limited, or non-existent, peer-reviewed clinical evidence base for their use. We continue to engage with the manufacturers of these products, encouraging them to bring their products to clinical trial. This would allow them to go through the medicine licensing process and be available to be considered for routine availability on the NHS through standard health technology appraisal processes.

Private prescription numbers for Cannabis Based products for Medicinal use (CBPMs) are not collected by the Scottish Government.

The Rural and Islands Housing Action Plan supports the delivery of the Scottish Government’s commitment to deliver 110,000 affordable homes, 10% of which will be in rural and island areas. The Scottish Government use the 6-fold urban rural classification when categorising homes delivered through the Affordable Housing Supply Programme (AHSP), based on information provided by AHSP grant applicants.